ZEPTIDE 2.5MG INJ

Zeptide 2.5mg Injection contains tirzepatide, a dual GIP and GLP-1 receptor agonist indicated for the management of Type 2 Diabetes Mellitus and weight-related conditions. It is administered once weekly and is designed to support blood glucose control and weight management when used alongside diet and physical activity.

Each prefilled syringe ensures accurate dosing and convenient administration under medical supervision.

Indications

Zeptide 2.5mg Injection is indicated for:

• Type 2 Diabetes Mellitus

  • As an adjunct to diet and exercise in adults with insufficient glycemic control

  • As monotherapy when metformin is unsuitable

  • In combination with other antidiabetic medications

• Weight Management

  • For adults with obesity

  • For overweight adults with at least one weight-related comorbid condition

• Obstructive Sleep Apnea (OSA)

  • For moderate to severe OSA in adults with obesity, alongside lifestyle modification

How It Works

Tirzepatide activates both:

• GIP (Glucose-dependent Insulinotropic Polypeptide) receptors

• GLP-1 (Glucagon-like Peptide-1) receptors

This dual mechanism:

• Enhances insulin secretion in a glucose-dependent manner

• Reduces glucagon levels

• Slows gastric emptying

• Helps regulate appetite

• Supports weight reduction

Its molecular structure allows albumin binding, prolonging its half-life for convenient once-weekly dosing.

Dosage & Administration

• Initial dose: 2.5 mg once weekly

• After 4 weeks: increase to 5 mg once weekly

• Further increases may be made in 2.5 mg increments every 4 weeks if required

• Maximum dose: 15 mg once weekly

Use strictly as prescribed by a qualified healthcare professional. Do not adjust the dose without medical advice.

Side Effects

Very Common

• Nausea

• Diarrhea

• Vomiting

• Abdominal pain

• Constipation

• Hypoglycemia (especially with insulin or sulfonylureas)

Common

• Decreased appetite

• Dizziness

• Fatigue

• Injection site reactions

• Dyspepsia

• Increased heart rate

Rare but Serious

• Acute pancreatitis

• Severe hypoglycemia

• Anaphylaxis or angioedema

Seek immediate medical attention if severe abdominal pain or allergic reactions occur.

Warnings & Precautions

Do not use if you have:

• A personal or family history of medullary thyroid carcinoma (MTC)

• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

• Known hypersensitivity to tirzepatide or any component of the formulation

Important Safety Information:

• Monitor for signs of pancreatitis

• Risk of hypoglycemia increases when combined with insulin or sulfonylureas

• May delay absorption of oral medications

• Oral contraceptive users should use additional contraception for 4 weeks after starting or increasing dose

• Consult your physician before use during pregnancy

Drug Interactions

Use caution when combined with:

• Insulin or sulfonylureas (dose adjustment may be required)

• Oral medications with a narrow therapeutic index (e.g., warfarin, digoxin)

• Oral hormonal contraceptives

Always inform your doctor about all medications you are taking.

Storage

Store at room temperature away from direct light and heat.
Do not freeze. Keep out of reach of children.

Pharmacy Assurance

• 100% genuine and verified product

• Proper storage and handling maintained

• Secure and reliable pharmacy dispensing

• Professional customer support for prescription processing

Disclaimer:
This product is for use under medical supervision only. The information provided is for educational purposes and should not replace professional medical advice. Always read the product label and consult your healthcare provider before use.